The first half of the book details Steve’s diagnosis, progression of the disease and attempts at treating it. Steve was an accountant, and Mary trained to be a neonatologist. Significant symptoms became evident in 2000-2001 when Steve started making mistakes in accounting. The most widely known markers for the disease are amyloid plaques and tangles in the brain; abnormal lipid deposits are also being studied. The complication has been that plagues & tangles seem secondary effects and just attempting to address that has not worked. It has been speculated that Alzheimer’s is Type 3 diabetes – Insulin resistance in the brain, where brain cells are unable to absorb the glucose they need. After the disease had progresses significantly for Steve, GlucoLife Blood Sugar Supplement Mary came across an article on the benefits of ketones in alleviating symptoms of Alzheimer’s. The theory is that ketones can supply alternate energy to brain cells since GlucoLife glucose formula is not making it there. She mentions she wishes she had known about this earlier as giving Steve coconut oil and MCT oil every day led to significant improvement and Steve himself mentioned that he felt as if the fog had lifted from his brain.

In parallel, they continued to check on drug trials Steve could participate in – though sadly it did not work out. Mary also worked to get the word out that ketones help – but she was largely ignored initially by research organizations. After a fall, and later seizures and complications thereof, Steve passed away in 2016. Mary continues to follow Alzheimer’s treatment developments, at the same time advocating ketones as an option, which has worked for many. There is detailed information in the later sections on – the disease (symptoms, diagnosis etc), diet advice (most significant triggers believed to processed food and sugars), letters outlining benefits others have written to her on using ketones and a few food recipes mostly with coconuts. Her efforts in supporting Steve for many years, without doubt also extending his life as a result, and getting the word out about ketones makes for inspiring reading. I believe this is well worth a try, considering the toll the disease takes. However, especially the first half of the book makes it appear as if ketones should be the primary focus of treatment. I personally liked the multi-faceted approach advocated in “The End of Alzheimer’s” by Dale Bredesen. Of course, based on the author’s personal experience, clearly ketones are worth exploring as an option at any stage of the disease.
Position: Is machine learning good or bad for GlucoLife Blood Sugar the natural sciences? Machine learning (ML) methods are having a huge impact across all of the sciences. However, ML has a strong ontology-in which only the data exist-and a strong epistemology-in which a model is considered good if it performs well on held-out training data. These philosophies are in strong conflict with both standard practices and key philosophies in the natural sciences. Here, we identify some locations for ML in the natural sciences at which the ontology and epistemology are valuable. For example, when an expressive machine learning model is used in a causal inference to represent the effects of confounders, such as foregrounds, backgrounds, or instrument calibration parameters, the model capacity and loose philosophy of ML can make the results more trustworthy. We also show that there are contexts in which the introduction of ML introduces strong, unwanted statistical biases. For one, when ML models are used to emulate physical (or first-principles) simulations, they introduce strong confirmation biases.
For another, when expressive regressions are used to label datasets, those labels cannot be used in downstream joint or ensemble analyses without taking on uncontrolled biases. The question in the title is being asked of all of the natural sciences; that is, we are calling on the scientific communities to take a step back and consider the role and value of ML in their fields; the (partial) answers we give here come from the particular perspective of physics. It is an understatement to say that machine learning (ML) is having a big impact across the sciences. A significant fraction of all scientific papers in the natural sciences now employ ML in part (or all) of their analyses. We will define ML below in Section 2). However, when we ask what scientific breakthroughs have been enabled by this influx of new tools and methods, there isn’t a long list. The success of the AlphaFold projects in protein structure (Jumper et al., 2021) are often raised.